Health - Google News: FDA Approves Omacetaxine (Synribo) for CML - Cancer Network

Health - Google News Google News

FDA Approves Omacetaxine (Synribo) for CML - Cancer Network Oct 26th 2012, 20:21 Haaretz FDA Approves Omacetaxine (Synribo) for CML Cancer Network The US Food and Drug Administration (FDA) today approved omacetaxine mepesuccinate (Synribo) for the treatment of adults with chronic myelogenous leukemia (CML) who are resistant to other therapies. The new drug is intended for patients whose ... FDA approves Synribo for patients with CMLHealio FDA approves Teva leukemia drugWHTC Synribo Approved to Treat Rare LeukemiaHealth.com all 53 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: